10-K: Lifeway Foods Achieves Record 2024 Net Sales, Driven by Strong Kefir Demand

Sentiment:

Annual Results 14 March 2025 9:00 AM

Lifeway Foods reports a 17% year-over-year increase in net sales for 2024, reaching $186.8 million, fueled by strong demand for its drinkable kefir.

Better than expectedThe company achieved record net sales, indicating better than expected performance.

Summary

Lifeway Foods announced record net sales of $186.8 million for the year ended December 31, 2024, representing a 17% increase compared to the previous year.
The growth was primarily driven by higher volumes of the company's branded drinkable kefir.
Fourth-quarter net sales reached $46.9 million, marking the 21st consecutive quarter of year-over-year growth.
The company is investing in its Waukesha, Wisconsin facility to almost double production capacity and more than triple bottling speed.
Lifeway is targeting Adjusted EBITDA of $45 $50 million in FY2027.
The company reported net income of $9.0 million, or $0.61 per basic share and $0.60 per diluted share, for the year ended December 31, 2024.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with record sales and strategic investments, indicating a favorable sentiment.

Positives

Strong net sales growth driven by increased demand for kefir products.
Continued investment in production capacity and efficiency.
Expansion of product distribution.
Focus on health and wellness trends to drive future growth.
The company is in compliance with all applicable financial debt covenants as of December 31, 2024.

Negatives

General and administrative expenses increased $6,309 to $19,439 during the year ended December 31, 2024 from $13,130 during the same period in 2023.
Legal and professional fees associated with non-routine stockholder action and the Danone unsolicited purchase proposal, and the CEO retention bonus awarded in the fourth quarter of 2024, account for approximately 75% of the increase.

Risks

The company faces competition from other dairy and non-dairy probiotic products.
Changes in consumer tastes and preferences could impact demand.
Interruption of the supply chain or manufacturing could affect the ability to produce and distribute products.
Cybersecurity threats could disrupt operations.
Increases in the cost of milk could reduce gross margin and profit.
The company is subject to various food, environmental, and health and safety laws and regulations.

Future Outlook

The company is targeting Adjusted EBITDA of $45 $50 million in FY2027 and expects to drive further operational efficiency across the business as it ships higher volumes of its products.

Management Comments

'I am pleased to report another record year of net sales for Lifeway, spearheaded by the continued, strong volume growth of our flagship drinkable Lifeway Kefir,' commented Julie Smolyansky, President and Chief Executive Officer of Lifeway.
'We recognize the tailwind from growing consumer interest in protein-rich foods with probiotics and bioavailable nutrients and have meaningfully invested in our core branded offerings to drive trial and accelerate velocities to capture a greater share of that demand,' added Ms. Smolyansky.
'2024 was an excellent year for Lifeway, and I am confident that we are extremely well positioned to deliver another phenomenal performance in 2025,' added Ms. Smolyansky.

Industry Context

The announcement highlights the growing consumer interest in probiotic foods and the company's efforts to capitalize on this trend. This aligns with the broader industry trend of increasing demand for functional foods and beverages that offer health benefits.

Comparison to Industry Standards

The document does not contain specific comparisons to industry standards or comparable companies.
Without more information, it is difficult to assess Lifeway's performance against global benchmarks.
To provide a more detailed assessment, specific comparable companies, projects, and results would need to be identified.

Stakeholder Impact

Shareholders will benefit from the increased net sales and profitability.
Employees may benefit from the company's growth and investments in its facilities.
Customers will have access to a wider range of Lifeway products through expanded distribution.

Next Steps

The company plans to continue investing behind key products to capture more of the growing market.
Lifeway will continue to evaluate opportunities to elevate the presence of its key branded products through expanded distribution.
The company is scheduled to upgrade its Waukesha plant to almost double production capacity and more than triple bottling speed.

Key Dates

Date	Description
1986	Lifeway was founded by Michael Smolyansky.
1988-03-29	Trading commenced on March 29, 1988.
1995	Private Securities Litigation Reform Act of 1995.
1999-10-01	Stockholders Agreement dated October 1, 1999 by and among Danone Foods, Inc., Lifeway Foods, Inc., Michael Smolyansky and certain other parties.
1999-12-24	Letter Agreement dated December 24, 1999 by and among Danone Foods, Inc., Lifeway Foods, Inc., Michael Smolyansky and certain other parties.
2002-09-12	Employment Agreement, dated September 12, 2002, between Lifeway Foods, Inc. and Julie Smolyansky.
2015-12-31	Lifeway stockholders approved the 2015 Omnibus Incentive Plan.
2018-05-07	Amended and Restated Loan and Security Agreement dated as of May 7, 2018 among Lifeway Foods, Inc., Fresh Made, Inc., The Lifeway Kefir Shop, LLC, Lifeway Wisconsin, Inc., and CIBC Bank USA, as Lender.
2018-10-29	Employment Agreement by and between the Company and Amy Feldman, dated as of October 29, 2018.
2019-01-18	Employment Agreement by and between the Company and Eric Hanson, dated as of January 18, 2019.
2019-04-10	First Modification to Amended and Restated Loan and Security Agreement dated as of April 10, 2019 among Lifeway Foods, Inc., Fresh Made, Inc., The Lifeway Kefir Shop, LLC, Lifeway Wisconsin, Inc., and CIBC Bank USA, as Lender.
2019-12-10	Second Modification to Amended and Restated Loan and Security Agreement, effective as of December 10, 2019 by and among Lifeway Foods, Inc., Fresh Made, Inc., The Lifeway Kefir Shop, LLC, Lifeway Wisconsin, Inc., and CIBC Bank USA, as Lender.
2020-09-30	Third Modification to Amended and Restated Loan and Security Agreement dated as of September 30, 2020 among Lifeway Foods, Inc., Fresh Made, Inc., The Lifeway Kefir Shop, LLC, Lifeway Wisconsin, Inc., and CIBC Bank USA, as Lender.
2021-08-18	Fourth Modification to Amended and Restated Loan and Security Agreement, dated as of August 18, 2021, by and among Lifeway Foods, Inc., Fresh Made, Inc., The Lifeway Kefir Shop, LLC, Lifeway Wisconsin, Inc., and CIBC Bank USA, as Lender
2022-07-27	Settlement Agreement dated as of July 27, 2022, between the Company and Edward Smolyansky and Ludmila Smolyansky.
2022-08-31	Lifeway stockholders approved the 2022 Plan.
2022-08-31	Lifeway stockholders approved the 2022 Non-Employee Director Equity and Deferred Compensation Plan (the 2022 Director Plan).
2024-08-12	This Insider Trading Policy describes the standards of Lifeway Foods and its subsidiaries (the Company) regarding trading in the stock and other securities of the Company while in possession of certain confidential information.
2024-09	Lifeway announced its first expansion of Kefir distribution in the South African market.
2024-10	Lifeway began to roll out its first products with 100% lactose-free labeling.
2024-11-04	The Company adopted a Shareholder Rights Agreement (the Rights Agreement) and designated 40 shares of preferred stock as Series A Junior Participating Preferred Stock, none of which are issued or outstanding as of December 31, 2024.
2024-11-05	The board of directors (our Board) determined that the unsolicited proposal made on September 23, 2024 by Danone North America PBC (Danone) to acquire all of the shares of the Company that it did not already own for $25.00 per share, substantially undervalued the Company and was not in the best interests of the Company or its stockholders or other stakeholders.
2024-11-15	Danone revised its offer to acquire all of the shares of the Company that it did not already own from $25.00 per share to $27.00 per share.
2024-11-20	The Boards determination that, after careful and thorough consideration in consultation with the Companys independent financial and legal advisors, the revised unsolicited proposal substantially undervalued the Company and was not in the best interests of the Company or its stockholders or other stakeholders.
2024-11-26	Additional information regarding the information the Board used to come to this determination.
2024-12-23	Amended and Restated Employment Agreement, dated as of December 23, 2024, by and between the Company and Julie Smolyansky.
2024-12-23	Retention Bonus Agreement, dated as of December 23, 2024, by and between the Company and Julie Smolyansky.
2025-02-05	The Company entered into the Fifth Modification to the Amended and Restated Loan and Security Agreement (the Fifth Modification) with its current lender.
2025-02-21	The Companys $1,800 equity investment in Simple Mills was liquidated as a result of the sale of Simple Mills.
2027	We remain confident that the Company is on track to deliver Adjusted EBITDA1 of $45 $50mm in FY2027.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.